136 related articles for article (PubMed ID: 7582946)
21. Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives.
Singh RK; Kumar S; Prasad DN; Bhardwaj TR
Eur J Med Chem; 2018 May; 151():401-433. PubMed ID: 29649739
[TBL] [Abstract][Full Text] [Related]
22. DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards.
Mattes WB; Hartley JA; Kohn KW
Nucleic Acids Res; 1986 Apr; 14(7):2971-87. PubMed ID: 3960738
[TBL] [Abstract][Full Text] [Related]
23. The mechanism of guanine alkylation by nitrogen mustards: a computational study.
Polavarapu A; Stillabower JA; Stubblefield SG; Taylor WM; Baik MH
J Org Chem; 2012 Jul; 77(14):5914-21. PubMed ID: 22681226
[TBL] [Abstract][Full Text] [Related]
24. The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agents.
Coley HM; Mongelli N; D'Incalci M
Biochem Pharmacol; 1993 Feb; 45(3):619-26. PubMed ID: 8442762
[TBL] [Abstract][Full Text] [Related]
25. Molecular dynamics simulations of chlorambucil/DNA adducts. A structural basis for the 5'-GNC interstrand DNA crosslink formed by nitrogen mustards.
Remias MG; Lee CS; Haworth IS
J Biomol Struct Dyn; 1995 Feb; 12(4):911-36. PubMed ID: 7779307
[TBL] [Abstract][Full Text] [Related]
26. DNA damage and mutagenesis induced by nitrogen mustards.
Povirk LF; Shuker DE
Mutat Res; 1994 Dec; 318(3):205-26. PubMed ID: 7527485
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, DNA binding and cytotoxicity of 1-[[omega-(9-acridinyl)amino]alkyl]carbonyl -3-(chloromethyl)-6-hydroxyindolines, a new class of DNA-targeted alkylating agents.
Fan JY; Tercel M; Denny WA
Anticancer Drug Des; 1997 Jun; 12(4):277-93. PubMed ID: 9199660
[TBL] [Abstract][Full Text] [Related]
28. DNA sequence- and structure-selective alkylation of guanine N2 in the DNA minor groove by ecteinascidin 743, a potent antitumor compound from the Caribbean tunicate Ecteinascidia turbinata.
Pommier Y; Kohlhagen G; Bailly C; Waring M; Mazumder A; Kohn KW
Biochemistry; 1996 Oct; 35(41):13303-9. PubMed ID: 8873596
[TBL] [Abstract][Full Text] [Related]
29. A novel synthetic DNA minor groove binder, MS-247: antitumor activity and cytotoxic mechanism.
Matsuba Y; Edatsugi H; Mita I; Matsunaga A; Nakanishi O
Cancer Chemother Pharmacol; 2000; 46(1):1-9. PubMed ID: 10912571
[TBL] [Abstract][Full Text] [Related]
30. Design and synthesis of a DNA-crosslinking azinomycin analogue.
Casely-Hayford MA; Pors K; James CH; Patterson LH; Hartley JA; Searcey M
Org Biomol Chem; 2005 Oct; 3(19):3585-9. PubMed ID: 16172698
[TBL] [Abstract][Full Text] [Related]
31. The 5'-GNC preference for mustard cross-linking is preserved in a restriction fragment.
Millard JT; Luedtke NW; Spencer RJ
Anticancer Drug Des; 1996 Sep; 11(6):485-92. PubMed ID: 8836112
[No Abstract] [Full Text] [Related]
32. Hypoxia-selective antitumor agents. 12. Nitrobenzyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine.
Tercel M; Wilson WR; Anderson RF; Denny WA
J Med Chem; 1996 Mar; 39(5):1084-94. PubMed ID: 8676343
[TBL] [Abstract][Full Text] [Related]
33. DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards is preserved in intact cells.
Hartley JA; Bingham JP; Souhami RL
Nucleic Acids Res; 1992 Jun; 20(12):3175-8. PubMed ID: 1620613
[TBL] [Abstract][Full Text] [Related]
34. Mutations induced by some DNA minor groove binding alkylators in AS52 Chinese hamster cells.
Wu XC; Marcinkowski K; Turner PM; Ferguson LR
Mutat Res; 2000 Mar; 448(1):35-45. PubMed ID: 10751621
[TBL] [Abstract][Full Text] [Related]
35. Effect of nucleosome structure on DNA interstrand cross-linking reactions.
Millard JT; Spencer RJ; Hopkins PB
Biochemistry; 1998 Apr; 37(15):5211-9. PubMed ID: 9548752
[TBL] [Abstract][Full Text] [Related]
36. Proteomic analysis of DNA-protein cross-linking by antitumor nitrogen mustards.
Loeber RL; Michaelson-Richie ED; Codreanu SG; Liebler DC; Campbell CR; Tretyakova NY
Chem Res Toxicol; 2009 Jun; 22(6):1151-62. PubMed ID: 19480393
[TBL] [Abstract][Full Text] [Related]
37. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
Cantrell JE; Green D; Schein PS
Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728
[TBL] [Abstract][Full Text] [Related]
38. DNA-directed alkylating agents. 6. Synthesis and antitumor activity of DNA minor groove-targeted aniline mustard analogues of pibenzimol (Hoechst 33258).
Gravatt GL; Baguley BC; Wilson WR; Denny WA
J Med Chem; 1994 Dec; 37(25):4338-45. PubMed ID: 7527862
[TBL] [Abstract][Full Text] [Related]
39. Structure of the d(CGCGAATTCGCG)2 complex of the minor groove binding alkylating agent alkamin studied by mass spectrometry.
Majid AM; Smythe G; Denny WA; Wakelin LP
Mol Pharmacol; 2007 Apr; 71(4):1165-78. PubMed ID: 17251328
[TBL] [Abstract][Full Text] [Related]
40. Thermolabile adenine adducts and A.T base pair substitutions induced by nitrogen mustard analogues in an SV40-based shuttle plasmid.
Wang P; Bauer GB; Bennett RA; Povirk LF
Biochemistry; 1991 Dec; 30(49):11515-21. PubMed ID: 1660721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
